🔎 Trials Near Me

Home › Cardiovascular Disease › Mississippi › Tupelo

Cardiovascular Disease clinical trials in Tupelo, MS

6 studies for Cardiovascular Disease are looking for participants at sites in and around Tupelo (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

RecruitingPhase 4
  • Cardiology Associates of North Mississippi, Tupelo
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT06909565

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

RecruitingPhase 3
  • Clinical Trial Site, Tupelo
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07181109

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

RecruitingPhase 3
  • Cardiology Associates Research LLC, Tupelo
Ages 50 to 105 · All sexes · Updated Aug 21, 2026 · NCT07136012

SPYRAL GEMINI Pilot Study

Recruiting
  • North Mississippi Medical Center, Tupelo
Ages 18 to 80 · All sexes · Updated Jun 24, 2026 · NCT06907147

MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels

Recruiting
  • North Mississippi Medical Center, Tupelo
Ages 18 to 80 · All sexes · Updated Sep 11, 2025 · NCT06271590

MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

Recruiting
  • Cardiology Associates Research, LLC, Tupelo
  • Cardiology Associates Research, LLC, Tupelo
Ages 18 to 110 · All sexes · Updated Feb 25, 2025 · NCT05908331

Cardiovascular Disease trials in other cities

Other studies in Tupelo

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.